Skip to content

attributable mortalitiy

attributable mortalitiy - attMo

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00013768
Enrollment
250
Registered
2018-01-29
Start date
2018-01-31
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OPS 8-987 Complex treatment for colonisation or infection with multi-resistant pathogens[MRE]

Interventions

Group 1: Retrospective Research of death cause in patients with multidrug resistens pathogens.

Sponsors

Helios Klinik Bad Saarow
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who have died in the year 2016 because of multidrug resistent infections in the clinics of Helios Berlin, Meckenburg-Vorpommern, Nordrhein-Westphalen, Hessen, Thüringen, Baden-Württemberg.

Exclusion criteria

Exclusion criteria: death caused by multidrug resistent infection but not in the year 2016

Design outcomes

Primary

MeasureTime frame
Questions: How many patients have died because of multidrug resistent pathogens versus how many patients have died who had a multidrug resistent infection but died because of other deseases. What could have been better in terms of the treatment (antibiotics, diagnostic)

Secondary

MeasureTime frame
potential of improvement in nosocomial infections

Countries

Germany

Contacts

Public ContactAlicia Neubeiser

Helios Klinik Berlin-Buch

alicia.neubeiser@helios-gesundheit.de015254777204

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026